Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alibaba Health Information Technology ( (HK:0241) ) has shared an update.
Alibaba Health Information Technology Limited has established a Nomination Committee to ensure effective governance and diversity within its board of directors. The committee will be composed mainly of independent non-executive directors and will focus on maintaining a diverse and skilled board to align with the company’s corporate strategy. This move is expected to enhance the company’s governance structure and support its strategic objectives by ensuring a balanced representation of skills and backgrounds on the board.
The most recent analyst rating on (HK:0241) stock is a Buy with a HK$4.20 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the health technology industry, focusing on providing digital health services and solutions. The company is incorporated in Bermuda and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 122,151,721
Technical Sentiment Signal: Buy
Current Market Cap: HK$81.88B
See more insights into 0241 stock on TipRanks’ Stock Analysis page.